Literature DB >> 18684872

"Spare-spleen-uximab" for chronic ITP.

Theodore E Warkentin1, Donald M Arnold.   

Abstract

Entities:  

Year:  2008        PMID： 18684872     DOI： 10.1182/blood-2008-06-159335

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

1.  Rituximab in immune thrombocytopenia: transient responses, low rate of sustained remissions and poor response to further therapy in refractory patients.

Authors:  Aamer Aleem; Ahmed S Alaskar; Farja Algahtani; Mushtaq Rather; Muhamad Hitham Almahayni; Abdulkarim Al-Momen
Journal:  Int J Hematol       Date:  2010-07-17       Impact factor: 2.490

2.  Rituximab leads to long remissions in patients with chronic immune thrombocytopenia.

Authors:  Khalid Al-Habsi; Murtadha Al-Khabori; Muhanna Al-Muslahi; Anil Pathare; Khalil Al-Farsi; Mohammed Al-Huneini; Sulayma Al-Lamki; Salam Al-Kindi
Journal:  Oman Med J       Date:  2015-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.